Recent insights have demonstrated that diminished DDAH activity is evident in a variety of conditions associated with endothelial dysfunction and it is considered as one of the potent mechanisms responsible for increased methylarginines and subsequent ADMA mediated eNOS impairment. The gene discussed is DDAH1; the disease is endothelial dysfunction.